MARKET IS OPEN
Loading latest tickers...

Market Indices

S&P 500
$7,818.93
+0.58%
NASDAQ 100
$31,224.47
+0.48%
DOW JONES
$51,521.00
+0.49%
NASDAQ Composite
$27,599.79
+0.45%
RUSSELL 2000
$2,813.40
-0.72%
CBOE VIX
$15.01
-3.29%

Sector Heatmap

Technology+0.53%
Financials+0.24%
Healthcare-0.17%
Consumer Cycl+1.20%
Consumer Staples+0.90%
Energy+0.47%
Industrials+0.87%
Materials+0.46%
Real Estate+1.06%
Utilities+2.98%
Comm Services+0.04%

NRXP — NRX Pharmaceuticals, Inc. Common Stock

Nasdaq

NRX Pharmaceuticals, Inc. Common Stock

CompareBack to Screener
$2.94
+0.07(+2.44%)
O
2.89
H
2.98
L
2.83
V
418K
⏱️ End-of-day dataAs of Oct 6, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

Chart

About NRXP

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateMay 25, 2021
Employees29
Stock ExchangeNasdaq
Ticker SymbolNRXP
Websitehttps://nrxpharma.com

Key Financial Statistics

Market Cap$125.77M
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$1.62 - $5.06
52-Week Avg Volume924.3K
VWAP$2.91
Transactions2,914
Total Recorded Bars1,348 days